30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

CartiHeal Study Enrolls 150th Patient -

CartiHeal successfully enrolled the 150th patient in the Investigational Device Exemption clinical study of the Agili-C™ implant. This is an increase from the 100th patient milestone achieved at the beginning of 4Q18. The objective of the ongoing study is to demonstrate superiority of the cell-free Agili-C implant vs. microfracture and debridement in the treatment of cartilage defects, in both arthritic knees and those without degenerative changes. A minimum of 250 patients is expected to be enrolled within the next nine to 12 months. (CartiHeal Ltd., 3/7/19)